Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmin Asberger

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medicina (Kaunas, Lithuania)|April 28, 2023
Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving ProcedureIsabell Ge, Carmen Geißler, Alexandra Geffroy, et al.
Archives of Gynecology and Obstetrics|March 21, 2023
[<sup>68</sup>Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancerKerstin Michalski, Katharina Müller-Peltzer, Ingolf Juhasz-Böss, et al.
Cancers|December 10, 2021
Gastrin-Releasing Peptide Receptor Antagonist [<sup>68</sup>Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast CancerKerstin Michalski, Lars Kemna, Jasmin Asberger, et al.
Cancers|May 11, 2024
Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center StudyIsabell Ge, Kai Berner, Marlene Mathis, et al.
Nuclear Medicine and Biology|May 31, 2020
Association between gastrin-releasing peptide receptor expression as assessed with [<sup>68</sup>Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancerKerstin Michalski, Christian Stoykow, Peter Bronsert, et al.
Endocrine Connections|October 28, 2020
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteinsJasmin Asberger, Thalia Erbes, Markus Jaeger, et al.
Experimental and Therapeutic Medicine|January 31, 2025
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?Jasmin Asberger, Isabell Ge, Benjamin Schmidt, et al.
Archives of Gynecology and Obstetrics|December 10, 2021
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control studyKai Berner, Marc Hirschfeld, Daniela Weiß, et al.
Clinical Breast Cancer|April 13, 2016
BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-AnalysisThalia Erbes, Elmar Stickeler, Gerta Rücker, et al.
International Journal of Oncology|December 3, 2019
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?Andrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medicina (Kaunas, Lithuania)|April 28, 2023
Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving ProcedureIsabell Ge, Carmen Geißler, Alexandra Geffroy, et al.
Archives of Gynecology and Obstetrics|March 21, 2023
[<sup>68</sup>Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancerKerstin Michalski, Katharina Müller-Peltzer, Ingolf Juhasz-Böss, et al.
Cancers|December 10, 2021
Gastrin-Releasing Peptide Receptor Antagonist [<sup>68</sup>Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast CancerKerstin Michalski, Lars Kemna, Jasmin Asberger, et al.
Cancers|May 11, 2024
Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center StudyIsabell Ge, Kai Berner, Marlene Mathis, et al.
Nuclear Medicine and Biology|May 31, 2020
Association between gastrin-releasing peptide receptor expression as assessed with [<sup>68</sup>Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancerKerstin Michalski, Christian Stoykow, Peter Bronsert, et al.
Endocrine Connections|October 28, 2020
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteinsJasmin Asberger, Thalia Erbes, Markus Jaeger, et al.
Experimental and Therapeutic Medicine|January 31, 2025
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?Jasmin Asberger, Isabell Ge, Benjamin Schmidt, et al.
Archives of Gynecology and Obstetrics|December 10, 2021
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control studyKai Berner, Marc Hirschfeld, Daniela Weiß, et al.
Clinical Breast Cancer|April 13, 2016
BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-AnalysisThalia Erbes, Elmar Stickeler, Gerta Rücker, et al.
International Journal of Oncology|December 3, 2019
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?Andrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Pageof 3